Lynn W. Enquist, Ph.D.
Biography and Research Interest
Lynn W. Enquist, Ph.D., is Henry L. Hillman Professor and Chair of the Department of Molecular Biology and Professor in the Princeton Neuroscience Institute at Princeton University. He received his BS degree from South Dakota State University and received his PhD in Microbiology from the Medical College of Virginia. His research interests are the genetics and molecular biology of DNA viruses with a special emphasis on neurotropic alpha herpes viruses. Dr. Enquist has published 239 articles or books and is an inventor on four US patents. He is the Editor-in-Chief of the Journal of Virology, a member of the National Science Advisory Board for Biosecurity, a member of the AAAS board of directors, and has served as a member and chair of several NIH grant review panels. He served as President of the American Society for Virology. He co-taught the Cold Spring Harbor summer course on Advanced Bacterial Genetics from 1980-1985. He is one of four authors of a popular virology textbook entitled: Principles of Virology, Molecular Biology, Pathogenesis, and Control. He was awarded the President's Award for Teaching Excellence at Princeton in 2001 for his course entitled "Viruses: Strategy and Tactics". He was appointed as a commissioner for the New Jersey Cancer Commission where he played a leadership role in state funding of cancer research and education. In 2010 he was elected to the American Academy of Arts and Sciences. He lectures widely on viruses.
Dr. Enquist's 30 year career experience has spanned research work in government laboratories at the NIH, heading research at Molecular Genetics, Inc. (one of the first biotechnology companies), designing novel applications of viruses for DuPont corporate research, managing an antiviral drug discovery team for DuPont Merck Pharmaceuticals to his current position as Henry L. Hillman Professor and Chair of Molecular Biology at Princeton University. His work on bacterial viruses played an important role in the development of recombinant DNA technology and his work on in vitro packaging systems has seen worldwide use by many investigators for cloning DNA from complex genomes into simple bacterial viruses. He was involved peripherally with the Recombinant DNA Advisory Committee on the use of recombinant DNA by participating in the certification of the first E. coli vector systems. He and his colleagues were involved in the first successful cloning of mammalian genes and viruses including those from herpes simplex virus type 1 as well as integrated murine RNA tumor virus genomes. His current work is devoted to understanding how viruses invade and cause disease in the nervous system as well as developing viruses as tools to study the vertebrate nervous system.